Persistent URL of this record https://hdl.handle.net/1887/101285
In Collections
This item can be found in the following collections:
![Odanacatib Anti-Fracture Efficacy and Safety in Postmenopausal Women with Osteoporosis. Results from the Phase III Long-Term Odanacatib Fracture Trial (LOFT)](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Odanacatib Anti-Fracture Efficacy and Safety in Postmenopausal Women with Osteoporosis. Results from the Phase III Long-Term Odanacatib Fracture Trial (LOFT)
- All authors
- McClung, M.; Langdahl, B.; Papapoulos, S.; Saag, K.; Adami, S.; Bone, H.; Villiers, T. de; Kiel, D.; Kung, A.; Kumar, P.; Lim, S.K.; Ling, X.; Lippuner, K.; Mautalen, C.; Nakamura, T.; Reginster, J.Y.; Reid, I.; Portales, J.R.; Roux, C.; Walliser, J.; Watts, N.; Zanchetta, J.R.; Zerbini, C.; Rybak-Feiglin, A.; Cohn, D.; DaSilva, C.; Massaad, R.; Santora, A.; Scott, B.; Verbruggen, N.; Leung, A.; Lombardi, A.
- Date
- 2014-02-28
- Volume
- 29
- Pages
- S51 - S51